Previously submitted to: JMIR Formative Research (no longer under consideration since Jul 15, 2023)
Date Submitted: Mar 12, 2020
Mobile-based Biometric: Sensor Proposal for Monitoring Relapse Salmonella Typhi Outpatients
Background:
Typhoid fever remains a major health problem in developing countries: According to the World Health Organisation, there are 21 million cases of Typhoid Fever worldwide and 222,000 typhoid-related deaths occurring annually. Relapsed typhoid fever patient needs to be equipped with resources and services to always monitor their symptoms.
Objective:
Our primary objective is to propose a mobile-based monitoring methodology, which uses vital signs monitoring apparatus, which is configured to recognise the characteristics of typhoid recurrence. Key to our design is the implementation of sensors for body temperature monitoring and physiological testing through galvanic skin response (GSR), electrocardiographic testing (ECG) and electromyography (EMG).
Methods:
Our observation is based upon Electrocardiogram (ECG) to capture heart rate signals by the electrodes attached to the participant’s body. The participants were healthy middle-aged male and female. Following-up the electromyography (EMG) evaluates the health condition of the participant’s muscles and the nerve cells that controls them (motor neurons) through pre-gelled electrodes attached to the participant and measurement taken every 30 seconds. If the test was to be on an aftercare typhoid patient the aim would be to evaluate muscle function post-typhoid and to check for any possibility of the patient going into a relapse. The galvanic skill response (GSR) modulates the level of sweat secretion from sweat glands.
Results:
Our experiments proved that all four biometric parameters work accurately for typical monitoring of physiological signals in real time.
Conclusions:
This research work proves that our pervasive typhoid fever outpatient self-monitoring sensor is more effective than Widal test and culture approaches because these techniques are expensive and test facilities are not readily available or are limited in areas where it is most needed.
ClinicalTrial:
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.